cryoICE cryoXT cryoablation probe (cryoXT)— 510(k) K250371

Substantially Equivalent

AtriCure, Inc.

FDA 510(k) clearance K250371 for cryoICE cryoXT cryoablation probe (cryoXT), Substantially Equivalent on 2025-04-10. Applicant: AtriCure, Inc..

Clearance details

Applicant: AtriCure, Inc.
Product code: Code GXH
Advisory panel: Neurology
Date received: 2025-02-10
Decision date: 2025-04-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mason, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.